Long-Term Lamotrigine Adjunctive to Antipsychotic Monotherapy in Schizophrenia: Further Evidence [2]

Canadian Journal of Psychiatry

Volumn 49, Issue 4, 2004, Pages 280-

  Kolivakis, Theodore T ^a   Beauclair, Linda ^a   Margolese, Howard C ^a   Chouinard, Guy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CLOZAPINE; HALOPERIDOL; LAMOTRIGINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LETTER; LONG TERM CARE; MALE; MONOTHERAPY; NEGATIVE SYNDROME; NEUROTRANSMITTER RELEASE; PATHOPHYSIOLOGY; POSITIVE SYNDROME; SCHIZOPHRENIA; SCORING SYSTEM;

EID: 2342552952     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370404900411     Document Type: Letter

References (9)

1. Wassef AA, Dott SG, Harris A, Brown A, O'Boyle M, Meyer WJ III, and others. Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia. J Clin Psychopharmacol 2000;20:357-61.
2. Dursun SM, McIntosh D, Milliken H. Clozapine plus lamotrigine in treatment-resistant schizophrenia. Arch Gen Psychiatry 1999;56:950.
3. Dursun SM, Deakin JF. Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study. J Psychopharmacol 2001;15:297-301.
4. Saba G, Dumortier G, Kalalou K, Benadhira R, Degrassat K, Glikman J, and others. Lamotrigine-clozapine combination in refractory schizophrenia: three cases. J Neuropsychiatry Clin Neurosci 2002;14:86.
5. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, and others. Clozapine treatment for suicidality in schizophrenia International Suicide Prevention Trial (InterSePT). Arch general Psychiatry 2003;60:82-91.
6. Goff DC, Coyle JT. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 2001;158:1367-77.
7. Anand A, Charney DS, Oren DA, Berman RM, Hu XS, Cappiello A, and others. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry 2000;57:270-6.
8. Olney JW, Newcomer JW, Farber NB. Is NMDA receptor hypofunction in schizophrenia associated with a primary hyperglutamatergic state? Arch Gen Psychiatry 2002;59:466-8.
9. Moghaddam B. Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol Psychiatry 2002;51:775-87.